top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Use of Straighteners and Other Hair Products and Incident Uterine Cancer
Hair products may contain hazardous chemicals with endocrine (hormone)-disrupting and carcinogenic (cancer-causing) properties.
Women's Cancer Research Foundation
Jan 13, 20232 min read
0 comments
Cardiovascular Disease Diagnoses Among Older Women with Endometrial Cancer
Endometrial cancer may be related to cardiovascular disease, yet little is known about the relationship between cardiovascular disease in...
Women's Cancer Research Foundation
Jan 4, 20231 min read
0 comments
Opportunistic Osteoporosis Screening in Gynecologic Cancer Survivors
Cancer treatment-induced bone loss is a known side effect of cancer therapy. A recent study evaluated routine computed tomography (CT) image
Women's Cancer Research Foundation
Dec 28, 20222 min read
0 comments
Frequent Aspirin Use and Ovarian Cancer Risk
Frequent aspirin use has been associated with reduced ovarian cancer risk, but no study has comprehensively assessed this effect.
Women's Cancer Research Foundation
Dec 20, 20221 min read
0 comments
Three Icons of Stage and Screen Lost to Ovarian Cancer
Judy Tenuta, Gilda Radner, and Cassandra Harris were wonderful comedians and actresses who brought joy to millions of people.
Women's Cancer Research Foundation
Oct 12, 20222 min read
0 comments
New Treatment Brings Remission of Rectal Cancer in All Patients
A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer...
Women's Cancer Research Foundation
Oct 11, 20221 min read
0 comments
Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older
In a recent study, researchers sought to assess the association between use of bisphosphonates and the risk of epithelial ovarian cancer.
Women's Cancer Research Foundation
Oct 5, 20221 min read
0 comments
Physical Activity and Gynecologic Cancer Outcomes
Physical activity is associated with improved cancer outcomes, but it is unclear which patients may benefit most from increased.....
Women's Cancer Research Foundation
Sep 20, 20221 min read
0 comments
‘Drug factory’ Implants Eliminate Ovarian, Colorectal Cancer in Mice
Rice University bioengineers have shown they can eradicate advanced-stage ovarian and colorectal cancer in mice in as little as six days.
Women's Cancer Research Foundation
Aug 31, 20221 min read
0 comments
Genetic Testing — A Game-Changer
Since 2003, when scientists successfully mapped the human genome, personalized cancer therapy has transformed cancer treatment.
Women's Cancer Research Foundation
Aug 23, 20221 min read
0 comments
Malnutrition As A Risk Factor for Post-operative Morbidity in Gynecologic Cancer
An article from Gynecologic Oncology reviewed the association between various malnutrition definitions with post-operative morbidity.
Women's Cancer Research Foundation
Aug 1, 20221 min read
0 comments
Risk of Cancer after Premenopausal Bilateral Oophorectomy
Women undergoing hysterectomy are commonly offered a bilateral oophorectomy for ovarian and breast cancer prevention.
Women's Cancer Research Foundation
Jul 28, 20222 min read
0 comments
Prevention of Ovarian Cancer
Risk reduction for women who carry BRCA1/2 mutations can achieve a 95% reduced risk of ovarian cancer through a risk-reducing...
Women's Cancer Research Foundation
Jul 26, 20222 min read
0 comments
Liquid Biopsy in Ovarian Cancer
In recent years there have been considerable efforts to develop a blood test or liquid biopsy...
Women's Cancer Research Foundation
Jul 20, 20221 min read
0 comments
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women
The average lifetime risk of developing ovarian cancer risk for women who harbor a BRCA1 or BRCA2 pathogenic germline mutation is 44% & 17%
Women's Cancer Research Foundation
Jul 11, 20222 min read
0 comments
Daily Aspirin Offers No Benefit in Breast Cancer Survivors
A recent study reported that daily intake of aspirin does not appear to prevent a recurrence of invasive breast cancer.
Women's Cancer Research Foundation
Jun 28, 20222 min read
0 comments
Impact of Care by Gynecologic Oncologists on Primary Ovarian Cancer Survival: Population-based Study
Prompt treatment of advanced-stage ovarian cancer by a gynecologic oncologist with a combination of surgery and chemotherapy is approved...
Women's Cancer Research Foundation
Jun 24, 20222 min read
0 comments
Contraceptive Use and the Risk of Ovarian Cancer Among Women With a BRCA1 or BRCA2 Mutation
Women with a BRCA1 and BRCA2 mutation have a higher lifetime risk of developing ovarian cancer.
Women's Cancer Research Foundation
Jun 15, 20222 min read
0 comments
Clinical Characteristics, Pregnancy Outcomes & Ovarian Function - A Retrospective Age-Matched Study
Researchers evaluated the prognosis and pregnancy outcomes of pregnancy-associated breast cancer, a rare disease with increasing incidence.
Women's Cancer Research Foundation
Apr 22, 20222 min read
0 comments
Breast Cancer and Community-Based Oncology Depression Screening Program
Researchers sought to examine if a greater proportion of breast cancer referrals to behavioral health could be achieved for patients in...
Women's Cancer Research Foundation
Apr 11, 20221 min read
0 comments
bottom of page